<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8804207</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1862</journal-id>
<journal-id journal-id-type="nlm-ta">Schizophr Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Schizophr. Res.</journal-id>
<journal-title-group>
<journal-title>Schizophrenia research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0920-9964</issn>
<issn pub-type="epub">1573-2509</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29525460</article-id>
<article-id pub-id-type="pmc">6103885</article-id>
<article-id pub-id-type="doi">10.1016/j.schres.2018.02.042</article-id>
<article-id pub-id-type="manuscript">NIHMS948845</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Swerdlow</surname>
<given-names>Neal R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Light</surname>
<given-names>Gregory A.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Psychiatry, University of California, San Diego, School of Medicine, La Jolla, CA</aff>
<aff id="A2">
<label>2</label>Research Service, VA San Diego Healthcare System, San Diego, CA</aff>
<author-notes>
<corresp id="FN1">Corresponding Author: Neal R. Swerdlow, M.D., Ph.D., Professor, Department of Psychiatry, UC San Diego School of Medicine, La Jolla, CA 92093-0804, <email>nswerdlow@ucsd.edu</email></corresp>
<fn fn-type="COI-statement" id="FN4">
<p><underline>Conflict of interest</underline>: Dr. Light has received consulting compensation from Astellas, Boehringer Ingelheim, Merck, Lundbeck, Neuroverse, NeuroSig and Takeda. Dr. Swerdlow reports no consulting compensation.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>7</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<volume>198</volume>
<fpage>1</fpage>
<lpage>5</lpage>
<!--elocation-id from pubmed: 10.1016/j.schres.2018.02.042-->
<kwd-group>
<kwd>antipsychotic</kwd>
<kwd>genetics</kwd>
<kwd>prepulse inhibition</kwd>
<kwd>schizophrenia</kwd>
<kwd>sensorimotor gating</kwd>
<kwd>startle reflex</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>